Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Merck & Co., Inc.
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:

- sale of pharmaceutical products (72.1%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;

- sale of vaccines (17%);

- sale of animal health products (9.4%);

- other (1.5%).

Net sales are distributed geographically as follows: the United States (43.4%), Europe/Middle East/Africa (27.1%), Japan (7.6%), China (6.8%), Asia/Pacific (6.3%), Latin America (5.3%) and other (3.5%).

Number of employees : 71 000 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Pharmaceutical37,68988.8%41,75189.6% +10.78%
Animal Health4,2129.9%4,3939.4% +4.3%
Other143.000.3%521.001.1% +264.34%
Other Segment250.000.6%175.000.4% -30%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States18,21242.9%20,32543.6% +11.6%
Europe, Middle East and Africa12,21328.8%12,70727.3% +4.04%
Japan3,2127.6%3,5837.7% +11.55%
China2,1845.1%3,2076.9% +46.84%
Asia Pacific2,9096.9%2,9436.3% +1.17%
Latin America2,4155.7%2,4695.3% +2.24%
Other1,1492.7%1,6063.4% +39.77%
Managers
NameAgeSinceTitle
Kenneth Frazier642011Chairman, President & Chief Executive Officer
Robert M. Davis532016CFO & Executive Vice President-Global Services
Sandy Tremps-2016Vice President-R&D IT CIO
Thomas Henry Glocer592007Independent Director
Leslie Brun662014Lead Independent Director
Patricia Russo661995Independent Director
Peter C. Wendell682003Independent Director
Thomas Robert Cech, Dr.712009Independent Director
Pamela J. Craig622015Independent Director
Paul B. Rothman, Dr.612015Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,577,191,385 2,521,800,319 70.5% 1,053,090,194 29.4% 70.5%
Shareholders
NameEquities%
The Vanguard Group, Inc. 204,131,242 8.09%
Capital Research & Management Co. 138,704,087 5.50%
SSgA Funds Management, Inc. 117,343,358 4.65%
BlackRock Fund Advisors 62,974,508 2.49%
Wellington Management Co. LLP 47,867,455 1.90%
Geode Capital Management LLC 39,876,903 1.58%
Capital Research & Management Co. (World Investors) 38,212,072 1.51%
Putnam LLC 36,951,155 1.46%
Northern Trust Investments, Inc.(Investment Management) 32,900,519 1.30%
Janus Capital Management LLC 29,308,122 1.16%
Holdings
NameEquities%Valuation
NGM Biopharmaceuticals, Inc. (NGM) 12,955,01619.0%255,732,016 USD
Alector, Inc. (ALEC) 3,545,7194.49%86,657,372 USD
Sutro Biopharma, Inc. (STRO) 2,723,5097.59%21,134,430 USD
KalVista Pharmaceuticals, Inc. (KALV) 1,070,5896.00%12,954,127 USD
4D pharma plc (DDDD) 7,661,0005.83%3,952,003 USD
Menlo Therapeutics Inc. (MNLO) 1,243,1680.74%2,150,681 USD
OpGen, Inc. (OPGN) 10,8270.072%22,087 USD
Markets and indexes
- NYSE
- Main Market
- DJIA / SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  MRK:US
- Reuters Code :  MRK.N
- Datastream Code :  U:MRK
Company contact information
Merck & Co., Inc.
2000 Road Galloping Hill
PO Box 100
NJ 07033 Kenilworth, New Jersey
États-Unis (les)

Phone : +1 908 423 1000
Fax : +1 908 735 1253
Internet : http://www.merck.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Merck & Co., Inc.
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
MERCK & CO., INC.-9.25%208 339
JOHNSON & JOHNSON1.01%383 760
ROCHE HOLDING AG0.67%296 096
PFIZER, INC.-2.12%213 750
NOVARTIS AG-17.88%182 470
ABBVIE INC.8.36%167 264
NOVO NORDISK A/S7.82%154 231
ASTRAZENECA PLC15.25%147 070
AMGEN INC.2.61%143 302
ELI LILLY AND COMPANY16.29%136 233
BRISTOL-MYERS SQUIBB COMPANY-7.93%132 729
SANOFI0.71%131 610
GLAXOSMITHKLINE PLC-10.88%100 031
CHUGAI PHARMACEUTICAL CO., LTD.45.92%73 669
JIANGSU HENGRUI MEDICINE CO., LTD.27.79%71 499
BAYER AG-19.70%65 363
ALLERGAN PLC0.97%63 659
DAIICHI SANKYO COMPANY, LIMITED26.96%56 776
TAKEDA PHARMACEUTICAL COMPANY LIMITED-10.18%55 371
ASTELLAS PHARMA INC.-8.32%29 003
CHANGCHUN HIGH & NEW TECHNOLOGY INDUSTRY (GROUP) INC.121.93%28 838